Case Study: Tate's Situation
Tate is a 30-year-old client with a history of schizophrenia. At 16, while in foster care, he began
showing prodromal symptoms, and by 17, he was experiencing hallucinations and delusions.
Diagnosed with schizophrenia, he was treated with risperidone, which effectively managed his
symptoms. After aging out of foster care at 18, he lacked a support system, consistent housing,
and experienced multiple acute psychotic episodes. Currently, he is prescribed olanzapine 15 mg
but struggles with medication adherence due to transportation issues. He self-medicates with
alcohol, lacks consistent employment, and relies on supplemental security income, food
assistance, and Medicaid.
Task:
1. Application of Course Knowledge
Discuss how a psychiatric mental health nurse practitioner can assist Tate in developing a viable
medication management plan.
2. Prescription Writing
Write an appropriate prescription for Tate, supported by evidence.
3. Community Resources
Identify housing and support resources available in your community that could benefit Tate.
4. Mental Health Clubhouse Model
Discuss how services provided by a mental health clubhouse model could benefit Tate. Include
the effectiveness of the model based on research findings.
1. Discuss how the psychiatric mental health nurse
practitioner could assist the client in the creation of
a more viable medication management plan.
To assist Tate in developing a more effective medication management plan, the
psychiatric mental health nurse practitioner (PMHNP) should adopt a comprehensive
approach. Initially, the PMHNP needs to create a personalized treatment plan that
considers Tate’s specific needs, medication history, and challenges with adherence.
Pharmacologically, considering Tate's history of inconsistent medication adherence, a
long-acting injectable antipsychotic like olanzapine pamoate could be more effective,
ensuring consistent medication delivery and reducing the risk of relapse. Careful
, titration of the dose is important to balance efficacy and minimize side effects, with
monitoring for weight gain, metabolic changes, and extrapyramidal symptoms (Riboldi
et al., 2022). Educating Tate about the importance of medication adherence, potential
side effects, and the risks associated with self-medication using alcohol is also essential.
Additionally, the PMHNP should collaborate with social workers to address social
determinants affecting Tate's adherence, such as securing stable housing, providing
transportation, and ensuring access to food and other essential resources.
Implementing a monitoring system to track Tate’s response to the medication, adjusting
the treatment as needed, and connecting him with community resources like peer support
groups and vocational training programs will provide further support and enhance his
overall well-being. Supportive services play a critical role in this plan. Assigning a case
manager can help Tate navigate the healthcare system, schedule appointments, and
ensure he has transportation to the community clinic. Connecting Tate with peer support
groups or specialists can offer encouragement, share experiences, and provide practical
advice on managing his condition. Counseling and therapy, either individual or group,
can address underlying issues contributing to his alcohol use and provide strategies for
coping with symptoms (Group Therapy Is as Effective as Individual Therapy, and More
Efficient. Here’s How to Do It Successfully, 2023). Facilitating access to transportation
services or vouchers ensures Tate can attend appointments regularly. Referring him to
substance use counseling or integrated treatment programs that address both his
schizophrenia and alcohol use is equally important. Utilizing technology, such as mobile
apps or automated phone calls, can provide medication reminders, while telehealth
appointments can reduce the need for transportation and make it easier for Tate to stay
connected with his healthcare provider.
2. Write a prescription appropriate for the client with evidence support.
Prescription
Patient Name: Tate
Date of birth: 07/18/1994
Medication: Olanzapine Pamoate
Dosage: 405 mg
Injectable volume: 150 mg/ml (range 1.0-2.7 ml)
Route: Intramuscular injection
Frequency: Once a month
Refills: 1
Provider Name: Sansita Bhatta, PMHNP
Tate is a 30-year-old client with a history of schizophrenia. At 16, while in foster care, he began
showing prodromal symptoms, and by 17, he was experiencing hallucinations and delusions.
Diagnosed with schizophrenia, he was treated with risperidone, which effectively managed his
symptoms. After aging out of foster care at 18, he lacked a support system, consistent housing,
and experienced multiple acute psychotic episodes. Currently, he is prescribed olanzapine 15 mg
but struggles with medication adherence due to transportation issues. He self-medicates with
alcohol, lacks consistent employment, and relies on supplemental security income, food
assistance, and Medicaid.
Task:
1. Application of Course Knowledge
Discuss how a psychiatric mental health nurse practitioner can assist Tate in developing a viable
medication management plan.
2. Prescription Writing
Write an appropriate prescription for Tate, supported by evidence.
3. Community Resources
Identify housing and support resources available in your community that could benefit Tate.
4. Mental Health Clubhouse Model
Discuss how services provided by a mental health clubhouse model could benefit Tate. Include
the effectiveness of the model based on research findings.
1. Discuss how the psychiatric mental health nurse
practitioner could assist the client in the creation of
a more viable medication management plan.
To assist Tate in developing a more effective medication management plan, the
psychiatric mental health nurse practitioner (PMHNP) should adopt a comprehensive
approach. Initially, the PMHNP needs to create a personalized treatment plan that
considers Tate’s specific needs, medication history, and challenges with adherence.
Pharmacologically, considering Tate's history of inconsistent medication adherence, a
long-acting injectable antipsychotic like olanzapine pamoate could be more effective,
ensuring consistent medication delivery and reducing the risk of relapse. Careful
, titration of the dose is important to balance efficacy and minimize side effects, with
monitoring for weight gain, metabolic changes, and extrapyramidal symptoms (Riboldi
et al., 2022). Educating Tate about the importance of medication adherence, potential
side effects, and the risks associated with self-medication using alcohol is also essential.
Additionally, the PMHNP should collaborate with social workers to address social
determinants affecting Tate's adherence, such as securing stable housing, providing
transportation, and ensuring access to food and other essential resources.
Implementing a monitoring system to track Tate’s response to the medication, adjusting
the treatment as needed, and connecting him with community resources like peer support
groups and vocational training programs will provide further support and enhance his
overall well-being. Supportive services play a critical role in this plan. Assigning a case
manager can help Tate navigate the healthcare system, schedule appointments, and
ensure he has transportation to the community clinic. Connecting Tate with peer support
groups or specialists can offer encouragement, share experiences, and provide practical
advice on managing his condition. Counseling and therapy, either individual or group,
can address underlying issues contributing to his alcohol use and provide strategies for
coping with symptoms (Group Therapy Is as Effective as Individual Therapy, and More
Efficient. Here’s How to Do It Successfully, 2023). Facilitating access to transportation
services or vouchers ensures Tate can attend appointments regularly. Referring him to
substance use counseling or integrated treatment programs that address both his
schizophrenia and alcohol use is equally important. Utilizing technology, such as mobile
apps or automated phone calls, can provide medication reminders, while telehealth
appointments can reduce the need for transportation and make it easier for Tate to stay
connected with his healthcare provider.
2. Write a prescription appropriate for the client with evidence support.
Prescription
Patient Name: Tate
Date of birth: 07/18/1994
Medication: Olanzapine Pamoate
Dosage: 405 mg
Injectable volume: 150 mg/ml (range 1.0-2.7 ml)
Route: Intramuscular injection
Frequency: Once a month
Refills: 1
Provider Name: Sansita Bhatta, PMHNP
